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The INK4 family of cyclin-dependent kinase (CDK) inhibitors negatively regulates cyclin D-dependent
CDK4 and CDK6 and induces the growth-suppressive function of Rb family proteins. Mutations in the Cdk4
gene conferring INK4 resistance are associated with familial and sporadic melanoma in humans and result in
a wide spectrum of tumors in mice, suggesting that INK4 is a major regulator of CDK4. Mice lacking the Cdk4
gene exhibit various defects in many organs associated with hypocellularity, whereas loss of the p18Ink4c gene
results in widespread hyperplasia and organomegaly. To genetically test the notion that the function of INK4
is dependent on CDK4, we generated p18; Cdk4 double-mutant mice and examined the organs and tissues
which developed abnormalities when either gene is deleted. We show here that, in all organs we have examined,
including pituitary, testis, pancreas, kidney, and adrenal gland, hyperproliferative phenotypes associated with
p18 loss were canceled. The double-mutant mice exhibited phenotypes very close to or indistinguishable from
that of Cdk4 single-mutant mice. Mice lacking p27Kip1 develop widespread hyperplasia and organomegaly
similar to those developed by p18-deficient mice. The p27; Cdk4 double-mutant mice, however, displayed
phenotypes intermediate between those of p27 and Cdk4 single-mutant mice. These results provide genetic
evidence that in mice p18Ink4c and p27Kip1 mediate the transduction of different cell growth and proliferation
signals to CDK4 and that p18Ink4c is functionally dependent on CDK4.
The progression of eukaryotic cells through different phases
of mitotic division is controlled primarily by the cyclin-depen-
dent kinase (CDK) whose activity is in turn balanced by its
activation by a requisite cyclin subunit and its inhibition by a
CDK inhibitor. In mammalian cells, there exist two distinct
families of CDK inhibitors. The p21 family includes three
related proteins, p21Cip1/Waf1, p27Kip1, and p57Kip2, which
evolved from a common ancestor that predates Caenorhabditis
elegans and plants. The p16 family consists of four closely
related members, p16Ink4a, p15Ink4b, p18Ink4c, and p19Ink4d, and
evolved later, after the emergence of vertebrates.
The physiologic significance of evolving a separate family of
CDK inhibitors and multiple members within each family in
mammalian cells is presumed to meet increasing needs for
integrating more intricate and multifaceted cell growth signals,
both intracellular and extracellular, into a single cell cycle
control machinery. Supporting this notion are the observations
that the expression of individual CDK inhibitor genes is acti-
vated selectively by different checkpoint pathways, displays dis-
tinct temporary and spatial patterns during both in vitro cell
differentiation and in vivo embryonic development, and is
maintained differentially in different adult and senescent tis-
sues. Further support for different physiologic functions of
individual CDK inhibitor genes in vivo comes from the genetic
analyses of mutant strains of mice with targeted mutation in
each of seven individual CDK inhibitor genes. Various differ-
ent phenotypes were observed in these mice, ranging from lack
of major defects after the loss of the p15 or the p19 gene (27,
55), compromised DNA damage response after inactivation of
the p21 gene (4, 8), increase of tumor development resulting
from loss of function of p16 (25, 45), and severe developmental
defects after p57 mutation (54) to widespread hyperplastic cell
proliferation and organomegaly in p18 and p27 null mice (14,
15, 23, 27, 37). Elucidation of the molecular pathways linking
various cell growth signals to the expression of individual CDK
inhibitor genes, however, remains a major challenge and has
only been validated in a few exceptional cases. Two examples
are the p53-mediated activation of p21 gene expression follow-
ing DNA damage (11) and transforming growth factor -me-
diated induction of p15Ink4b (17).
Biochemically, CDK inhibitors within each family act almost
indistinguishably in binding to and regulating CDK enzymes
but differ among the families. The CIP/KIP proteins share a
unique N-terminal sequence motif comprising two subdomains
for binding cooperatively to and forming ternary complexes
with CDK and cyclin subunits. The CIP/KIP proteins diverge
in their C-terminal sequences. The INK4 proteins, on the other
hand, consist essentially of four or five tandem copies of
ankyrin repeats and few additional sequences. Unlike CIP/KIP
inhibitors, which are capable of interacting with multiple CDK-
cyclin complexes, the only binding partners and functional
targets identified thus far for INK4 proteins are two very
closely related catalytic CDK subunits, CDK4 and CDK6. Such
functional dependency of INK4 on CDK4 or CDK6, however,
has not yet been tested genetically.
Ectopic overexpression of individual INK4 genes causes a
G1 cell cycle arrest with a correlative dependency on the intact
Rb pathway (16), and loss of either Rb function or a combi-
nation of p107 and p130 functions effectively canceled the G1
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arrest due to INK4 overexpression (3, 24, 35). These findings
provide evidence that, at least in cultured cells, the function of
INK4, and CDK4 and CDK6 by extension, in controlling the
G1-to-S transition is dependent on the presence of both an
intact Rb and p107-p130 functions. Hence, there may exist in
vivo a linear INK4-CDK4/CDK6 (CDK4/6)-Rb G1 control
pathway in mammalian cells. Delineating the pathway(s) for
p21 family inhibitors in vivo is more complicated and remains
somewhat perplexing; this pathway is attributed largely to their
interaction with both the CDK and cyclin subunits and with
multiple CDK-cyclin complexes. It was initially observed that
p21 levels undergo an increase immediately following mito-
genic stimulation of serum-starved human fibroblasts, before
declining at the G1-S boundary (29), and that CDK and cyclin
can be found in active CDK-cyclin complexes at a one-to-one
ratio when expressed at a low concentration (18, 53). Later
studies found that the assembly and kinase activity of CDK4-
cyclin D correlate concomitantly with the binding of CIP/KIP
proteins (26) and were reduced in mouse embryonic fibroblasts
(MEFs) lacking p21 and p27 (6). A titration model—cyclin
Ds-CDK4/6 complexes act as activators of cyclin Es-CDK2
complexes by titrating CIP/KIP proteins away from, and thus
releasing the inhibition of, cyclin Es-CDK2 complexes—was
proposed to accommodate these observations, which seem-
ingly contradict the classification of CIP/KIP as a CDK inhib-
itor. According to this model, CIP/KIP genes can be consid-
ered to act genetically downstream of cyclin Ds-CDK4 complexes
in an INK4-cyclin Ds/CDK4-CIP/KIP-cyclin Es/CDK2-Rb
pathway. Results challenging both notions—that p21 only sto-
ichiometrically inhibits cyclin A-CDK2 and that p21-p27 defi-
ciency reduced cyclin D-CDK4 assembly and activity—were
reported (1, 19), leaving the mechanistic role of CIP/KIP pro-
teins in regulating cyclin Ds-CDK4/6 and cyclin Es-CDK2
complexes at an incompletely understood and somewhat con-
fusing state at present.
The p18Ink4c and p27Kip1 genes represent two of the most
extensively studied CDK inhibitor genes in mice. Loss of func-
tion of either gene resulted in similar and widespread defects
in cell proliferation and organ development, providing suitable
models for investigating the functional and mechanistic differ-
ences between the two families of CDK inhibitors in living
animals. In this study, we set forth to test genetically in double-
mutant mice the following questions: is the function of INK4 to
inhibit CDK4, and how does the loss of Cdk4 and a gene from
either CDK inhibitor family affect each other phenotypically in
mice?
MATERIALS AND METHODS
Generation of mouse strains. The generation of p18 and Cdk4 mutant mice
has been described previously (15, 49). Both have been backcrossed into and
maintained on an enriched C57BL/6 background as previously reported (2, 49).
Mice deficient for p18 were bred to the mice heterozygous for Cdk4 to create
double-heterozygous mice. Mice heterozygous for p18 and Cdk4 were inter-
crossed to generate all of the genotypes analyzed in this study. Animals were
genotyped by PCR and monitored as described previously (15, 49). Cohorts were
housed and analyzed in a common setting, and littermate controls were used for
all experiments.
Analysis of fertility and diabetes. Mating ability and fertility of mice were
determined by keeping each mutant and a wild-type fertile partner together in a
cage and checking daily for the presence of a vaginal plug. Females with plugs
were separated and monitored throughout pregnancy, delivery, and nursing.
Blood glucose level was monitored in the morning (8 to 10 a.m.) by using an
automatic glucose monitor (Glucometer Elite; Bayer). Each mouse was analyzed
twice for blood glucose on two consecutive days for every time point.
Histopathology. Tissues of most organs were removed, fixed in 10% neutral
buffered formalin, and examined histologically by two pathologists after hema-
toxylin-eosin staining. Lesions were photographed, and additional sections were
taken for immunohistochemical analyses.
Pancreatic islet size determination. Pancreatic islet size (cells per islet section)
was measured as previously reported with minor modifications (33). Briefly, islet
size was determined in at least three cut sections from matched pancreatic
regions of three animals per genotype at each stage of development. Sections
were more than 500 m from each other to avoid overestimating larger islets in
this analysis.
Immunohistochemistry. To measure proliferating and mitotic cells, sections
were blocked with normal goat serum in phosphate-buffered saline (PBS) and
incubated with either a polyclonal antibody against mitosis-specific phosphory-
lated histone H3 (5 g ml1; Upstate Biotechnology) or a polyclonal antibody
against Ki67 (1:1,000; NCL-Ki67; Novocastra Laboratories) for 1 h and with a
biotin-conjugated secondary antibody (Vector Laboratories) for 30 min. Immu-
nocomplexes were detected with the Vectastain ABC alkaline phosphatase kit
according to the manufacturer’s instructions (Vector Laboratories). For apopto-
sis assays, terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end
labeling (TUNEL) assays were carried out using the in situ ApopTag kit (Inter-
gen) according to the manufacturer’s protocol.
MEFs and flow cytometry procedures. Primary MEFs were isolated from
embryonic day 13.5 embryos. Early-passage MEFs (younger than passage 4)
from individual embryos were plated in 100-mm plates and incubated in Dul-
becco’s modified Eagle medium (DMEM) plus 10% fetal bovine serum (FBS).
For serum starvation, asynchronous cultures at approximately 50% confluence
were washed with PBS and serum starved in DMEM containing 0.1% FBS for
72 h. Cells were restimulated by addition of DMEM with 10% FBS. For bro-
modeoxyuridine (BrdU) labeling, MEFs were grown in media with or without
serum containing 10 M BrdU for 1 h. Nuclei were isolated following trypsiniza-
tion and fixation with 95% ethanol by incubation in 0.08% pepsin (Sigma)–0.1 N
HCl for 20 min at 37°C. Nuclear DNA was denatured by incubation in 2 N HCl
for 20 min at 37°C, followed by neutralization with Na2B4O7, pH 8.5. Incorpo-
rated BrdU was detected with anti-BrdU-fluorescein isothiocyanate (Becton
Dickinson; 1:10 dilution) in 10 mM HEPES (pH 7.3)–150 mM NaCl–4% FBS–
0.5% Tween 20. MEFs were then harvested and resuspended in PBS containing
1% FBS and incubated with propidium iodide (5 g ml1) and RNase A (0.1 mg
ml1) for 30 min at 37°C. The samples were analyzed with a B-D FACScan
(Becton Dickinson), and the data were processed with Summit software (version
3.0; BD Biosciences).
Northern blot analysis. MEFs at early passage were serum deprived (0.1%
FBS) for 3 days and released from quiescence by serum stimulation (10% FBS).
Total RNA was prepared from cells at different time points after serum stimu-
lation as well as from an asynchronized cell population. RNA samples were
resolved on a 1% agarose gel, transferred to a nitrocellulose filter, and hybridized
with a probe derived from full-length mouse p18Ink4c cDNA. The blot was then
stripped and rehybridized with a mouse GAPDH (glyceraldehyde-3-phosphate
dehydrogenase) probe.
RESULTS
Loss of Cdk4 prevented gigantism of p18 mutant mice but
only partially rescued gigantism of p27 mutant mice. Mutant
p18/; Cdk4/, p18/; Cdk4/, p18/; Cdk4/, and
p18/; Cdk4/ mice were generated from mating double-
heterozygote p18/; Cdk4/ mice. p18/; Cdk4/ mice
were born with a ratio of 4.4% (8 of 183), lower than their
wild-type (9.3%, 17 of 183) and p18/; Cdk4/ (10.4%, 19 of
183) siblings, but comparable to Cdk4/ littermates (3.8%, 7
of 183; Table 1). These results indicate that disruption of Cdk4
may induce a prenatal lethality with incomplete penetrance as
previously reported (40) and that deletion of p18 has no sig-
nificant effect on prenatal lethality caused by Cdk4 deficiency.
At birth, Cdk4/, p18/, and p18/; Cdk4/ double-
mutant mice of various genotypes appeared indistinguishable
(data not shown). Soon after birth, however, various growth
abnormalities were grossly apparent. While the p18/ mice
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lived up to 1 year, at which time they developed both pituitary
tumors and lymphomas, the majority of Cdk4/ mice died
early in life (4 months) as previously reported (40, 49), but 5
to 10% of Cdk4/ mice survived up to 1 year without diabetes
(our unpublished results). The genetic basis for this incomplete
penetrance of the diabetes phenotype resulting from Cdk4 loss
is not clear at present. Loss of p18 had no significant effect on
the postnatal mortality caused by Cdk4 loss or on the devel-
opment of double-mutant mice. No p18/; Cdk4/ (n  9)
or p18/; Cdk4/ (n  11) animal lived beyond 5 months.
Growth retardation of p18/; Cdk4/ mice became obvi-
ous during prepuberty, was persistent through the entire ex-
perimental duration of 9 weeks, and was observed in both
sexes. The body weights of both p18/; Cdk4/ and p18/;
Cdk4/ mice were lower than those of either p18/ or wild-
type mice and were statistically indistinguishable from those of
Cdk4/ single null mice (Fig. 1A and C). Thus, loss of Cdk4
led to a body weight phenotype that was completely dominant
over loss of p18.
Loss of function of the p27 gene similarly resulted in an
increased body weight, as seen in mice with the p18 mutation
(14, 23, 37). To determine how Cdk4 and p27 genes interact
with each other in controlling the body weight, we analyzed the
p27 Cdk4 double-mutant mice. The p27/; Cdk4/ double-
mutant mice exhibited a body weight intermediate between
those of the single-homozygous mutant mice (Fig. 1B), indi-
cating that loss of Cdk4 and p27 partially rescued the body
weight abnormality caused by the loss of the other gene. To-
gether, these results demonstrate that, although p18 and p27
gene disruption resulted in a wide range of similar phenotypes
in mice, these two genes do not have the same mechanism for
regulation of Cdk4 in vivo. While the phenotype caused by p18
inactivation was completely dependent on CDK4, the function
of p27 was only partially dependent on CDK4.
Both male and female p18/; Cdk4/ mice are infertile.
All p18/; Cdk4/ mice, both males (n  8) and females (n
 10), that we examined are infertile, and most (more than
90%) of Cdk4/ males and all female mutants are sterile, as
reported previously. In contrast to testes enlargement caused
by p18 loss, the testes of 5-month-old p18/; Cdk4/ mice
were small and had sizes comparable to those of testes of
Cdk4/ mice (Fig. 2A). Histological analysis revealed that,
while p18/ male mice developed Leydig cell hyperplasia, the
p18/; Cdk4/ male mouse, like the Cdk4/ mouse, con-
tains abnormal seminiferous tubules with degeneration of a
significant fraction of primary spermatocytes and reduced Ley-
dig cells. Very few normal spermatozoa were found in the
lumen of seminiferous tubules of both Cdk4/ and p18/;
Cdk4/ mice at an age of 5 months (Fig. 2A). Hence, the
seminiferous tubules in mice lacking both Cdk4 and p18 genes
exhibited defects similar to those found in Cdk4/ mice. Ley-
dig cell proliferation associated with p18 loss was inhibited by
Cdk4 loss.
p18/ females are fertile and can mate successfully with
wild-type or p18/ males (15). Litter numbers and sizes of
mice produced from p18/ matings were bigger than those for
age-matched wild-type mating controls (F. Bai and Y. Xiong,
unpublished data). p18/ ovaries are bigger (twice as big as
the wild type), displayed normal antral follicles, and formed
many corpus lutea (CL). These results suggest that, despite
ovarian enlargement, ovulation from p18/ mice was not im-
paired. Cdk4/ female mice, like p27/ female mice, are
infertile. Adult Cdk4/ ovaries were 20 to 30% smaller than
those of wild-type females and showed some well-developed
antral follicles but very few CL (at most one CL in each ovary).
Very similar to Cdk4/ ovaries, p18/; Cdk4/ ovaries
were small and rarely developed CL at 4 months of age, when
many CL were found in littermate wild-type and p18/ con-
trol ovaries (Fig. 2), indicating that loss of p18 does not alle-
viate the infertility caused by defective luteal function in Cdk4-
deficient mice.
Loss of p27 also resulted in the development of ovarian
enlargement but impaired the function of ovulation and caused
female sterility (14, 23, 37, 42, 47), indicating that p18 and p27
play different roles in ovulation and granulosa cell prolifera-
tion. p27/; Cdk4/ female (as well as male) mice are infer-
tile.
Development of pituitary hyperplasia in p18/ mice re-
quires CDK4 function. A hallmark defect in mice with reduced
or complete loss of Rb function is the hyperplastic phenotype
of the pituitary (20, 21, 28, 31, 51). Loss of p18 results in the
development of the same hyperplastic phenotype in the inter-
mediate lobe of the pituitary (15, 27) (Fig. 3A) and, conversely,
loss of Cdk4 causes a pituitary hypoplasia and lactotroph dys-
function (36), offering an excellent in vivo setting to determine
the genetic interaction between these two Rb regulators. We
confirmed that pituitaries of Cdk4 null adult mice (4 months
old) were significantly smaller and extremely hypoplastic rela-
tive to wild-type pituitaries in all three lobes: the intermediate
lobe, the anterior lobe, and the neurohypophysis (Fig. 3A).
The pituitaries of p18/; Cdk4/ mice were as small as Cdk4
null pituitaries and also showed significant hypoplasia, which
might be responsible for the infertility and defect in formation
of CL in p18/; Cdk4/ mice. Like those from pituitaries of
Cdk4 single-knockout mice, the intermediate lobes from p18/;
Cdk4/ pituitaries were hypoplastic, indicating that the de-
velopment of pituitary hyperplasia in p18/ mice requires a
functional CDK4. Late in life (9 months), p18/ mice de-
veloped pituitary adenomas in the intermediate lobe. Because
of early death of p18/; Cdk4/ mice, we were not able to
TABLE 1. Incomplete penetrance of prenatal lethality in Cdk4 mutant and double-mutant micea
Progeny



















Observed 17 (9.3%) 25 (13.7%) 7 (3.8%) 27 (14.8%) 40 (21.9%) 16 (8.7%) 19 (10.4%) 24 (13.1%) 8 (4.4%)
Expected 11 (6.3%) 23 (12.5%) 11 (6.3%) 23 (12.5%) 46 (25%) 23 (12.5%) 11 (6.3%) 23 (12.5%) 11 (6.3%)
a Newborn pups were assessed for viability and genotyped. Mice were derived from p18/; Cdk4/ intercross (183 pups in 19 litters).
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demonstrate that loss of Cdk4 would prevent the development
of pituitary adenomas.
To determine the cellular basis of functional dependency of
p18 on Cdk4, we examined two cellular defects, apoptotic cell
death and cell proliferation, often associated with an alteration
of genes involved in the Rb pathway. Pituitary glands were
isolated from mice of different genotypes. Serial sections were
examined by TUNEL assay to determine the level of apoptosis,
by Ki-67 staining to determine the level of cell proliferations,
and by staining with an antibody against phosphorylated his-
tone H3 to determine mitotic index. Apoptosis in any of the
three lobes of the wild-type pituitary was nearly undetectable
(Fig. 3B). In the p18/ pituitary, apoptosis was barely detect-
able in both the intermediate lobe and neurohypophysis and
was very low in the anterior lobe (Fig. 3B), indicating that an
abnormal hyperproliferation caused by p18 loss is not associ-
ated with an increase of apoptosis and that a net increase of
cell number is therefore responsible for the increase in the size
of the intermediate lobe. Loss of Cdk4 and p18 did not cause
a detectable increase of apoptosis in both the intermediate
lobe and neurohypophysis. But loss of Cdk4 substantially in-
creased the apoptotic cell death in the anterior lobe, which
might be responsible for defective prolactin production and CL
formation. Deletion of the p18 gene did not detectably reduce
the apoptosis caused by Cdk4 loss in the anterior lobe of the
p18/; Cdk4/ pituitary (Fig. 3B).
Both Ki-67 and phosphor-H3 staining revealed an increase
of cell proliferation in the p18/ pituitary and a decrease of
cell proliferation to almost the basal level in the Cdk4/
pituitary (Fig. 3B). Increase of both Ki-67- and phosphor-H3
positive cells in the p18/ pituitary is not restricted to the
intermediate lobe; it is also evidently in both the anterior lobe
and the neurohypophysis (Fig. 3B), revealing a previously un-
recognized function of p18 in these parts of the pituitary.
Consistent with these results, we also found that p18 is ex-
pressed in all three lobes of the pituitary (data not shown). As
apoptosis in both cell types was not significantly increased, an
increase of cell proliferation, but not the size of both anterior
lobe and neurohypophysis, suggests that a separate compen-
sating mechanism may maintain an overall normal tissue size in
these parts of pituitary. The numbers of both Ki-67- and phos-
phor-H3-positive cells in the p18/; Cdk4/ pituitary were
similar to those seen in the wild type, indicating that loss of the
Cdk4 gene inhibited hyperproliferation caused by p18 loss.
Loss of p18 does not rescue diabetes of Cdk4-deficient mice.
Cdk4-deficient mice displayed normoglycemia at 3 weeks of
age and developed diabetes around 7 weeks of age (40, 49)
(Fig. 4A). Histological analysis revealed that by the age of 3
weeks the number and size of pancreatic islets were not af-
fected by the loss of CDK4. However, by the ages of 7 and 16
weeks the number of pancreatic islets was significantly de-
creased. Pancreases of wild-type mice showed 82.6, 16.6, and
0.8% small, medium, and large islets, respectively (Fig. 4B and
C). The number of islets from Cdk4/ mice was 50% less than
the number from wild-type littermate mice (Fig. 4B and data
not shown). Analysis of the sizes of the islets found in Cdk4/
pancreases of mice at 16 weeks of age revealed that 96.8%
were small (1 to 40 cells/islet section), that only 3.2% were
medium sized (41 to 400 cells/islet section), and that there
were no large-sized islets (400 cells/islet section). These re-
sults suggest that not only islet number but also the size of the
islets were significantly decreased in Cdk4-deficient mice. In
contrast, the number of islets from p18/ mice (16 weeks of
age) was approximately 40% higher than the number from
wild-type littermate mice. Although most of the islets of
p18/ mice (72.1%) were small, there were significantly more
FIG. 1. Effect of the loss of Cdk4, p18, and p27 on animal growth.
(A) Body weight comparison for male and female mice of different
genotypes. Mice from every genotype (four to six each) were weighed
from age 3 to 9 weeks. Standard deviation bars are indicated. , P 
0.001, for comparison of p18/; Cdk4/ mice to p18/ mice; #, P 
0.05 (no significant difference), for comparison of p18/; Cdk4/
mice to Cdk4/ mice (Student’s t test). (B) Body weight comparison
of Cdk4/, p27/, and p27/; Cdk4/ mutant male mice. Mice
from each genotype (three or four each) were weighed from age of 3
to 7 weeks. Standard deviation bars are indicated. , P  0.05, for
comparison of p27/; Cdk4/ mice to Cdk4/ or p27/ mice
(Student’s t test). (C) p18/, wild-type (WT), Cdk4/, and p18/;
Cdk4/ mice at 4 months of age.
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FIG. 2. Infertility of p18/; Cdk4/ mice. (A) Gross appearance of testes from 5-month-old mice (upper row) and sections of testes stained
with hematoxylin and eosin (HE) from mice of different genotypes at 5 months of age. WT, wild type. Bars, 200 m. (B) Sections of ovary stained
with HE from mice of different genotypes from the same litter at 4 months of age. The CL is indicated. Bars, 1 mm.
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FIG. 3. Abnormalities of the pituitary in p18 and Cdk4 mutant mice. (A) Pituitary glands (arrows) from mice of different genotypes from the
same litter were microscopically examined at 4 months of age either directly (top row) or after hematoxylin and eosin staining (bottom row). The
anterior lobe (A), intermediate lobe (I), and neurohypophysis (N) are indicated. The width of the intermediate lobe is shown by the black bars.
WT, wild type. Bars, 1 mm (top row) and 50 m (bottom row) (B) Series of sections of pituitary glands from littermate mice of different genotypes
at 4 months of age were examined for apoptotic cell death by TUNEL assay (top), for cell proliferation by Ki-67 staining (middle), and for mitotic
activity by immunostaining with an antibody recognizing phosphorylated histone H3 (bottom). Arrows, positive (brown staining or blue staining)
cells. Bars, 200 m.
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medium-sized (23.1%) and especially large-sized islets (4.6%)
than were found in wild-type mice (Fig. 4B). Pancreases of
p18/; Cdk4/ mice are very similar to those of Cdk4/
mice; islets were sparsely located in the p18/; Cdk4/ pan-
creas, and the number of islets was comparable to the number
in Cdk4/ mice. For the p18/; Cdk4/ islets, 95.5% were
small and only 4.5% could grow to medium size. No large-sized
islets were found in p18/; Cdk4/ pancreases (Fig. 4C).
Consistent with the defects in pancreatic development and
function, p18/; Cdk4/ mice also developed diabetes from
about 7 weeks of age (Fig. 4A). Loss of p18 did not rescue
defective pancreatic islet (-cell) development. Instead, loss of
Cdk4 abolished all hyperplastic growth of pancreatic islet 
cells caused by p18 loss.
Cdk4 and p18 are dispensable for retinal development. Rb
family proteins play an important role in retinal development.
Inactivation of Rb and/or p107 leads to multiple retinal dys-
plasia (31, 32, 41, 50). Loss of cyclin D1 results in small eyes
with thin retinas and a dramatic reduction in cell numbers in all
layers of the retina as the result of decreased cell proliferation
and increased apoptosis (13, 30, 46), implying a possible role
for CDK4 and/or CDK6 and INK4 in normal retinal develop-
ment through controlling the phosphorylation and activity of
Rb proteins. Close examination of retinas of Cdk4/, p18/,
and p18/; Cdk4/ mice did not identify any obvious abnor-
mality (Fig. 5), indicating that CDK4 and p18 are both dis-
pensable in retinal development. These findings suggest that
CDK6 is likely to play a prominent role in controlling retinal
development. In contrast to cyclin D1-deficient retinas, p27-
deficient retinas developed hyperproliferation and displayed
disorganized cellular layers and protrusions of the outer pho-
toreceptor cell layer into the rod-and-cone layer (10, 48). Si-
multaneous deletion of p27 and cyclin D1 rescued hyperprolif-
eration and hypocellularity caused by the deletion of either
gene and largely restored normal retinal development (48),
providing further evidence for a functional distinction between
p18 and p27 in controlling cyclin D-dependent kinases.
Cdk4 is required for development of kidney, adrenal glands,
and seminal vesicles, and deletion of p18 does not restore the
developmental defects of these organs in Cdk4 null mice. De-
letion of Cdk4 resulted in small kidney, adrenal glands, and
seminal vesicles. These three organs are 55% of the sizes of the
wild-type counterparts. Histologically, loss of Cdk4 resulted in
severe hypoplasia in these organs (Fig. 6 and data not shown).
In contrast, deletion of the p18 gene resulted in increased sizes
of kidney, adrenal glands, and seminal vesicles (15) (Fig. 6).
Deletion of p18 did not rescue hypoproliferative phenotypes
associated with Cdk4-deficient mice. The kidneys, adrenal
glands, and seminal vesicles of p18/; Cdk4/ mice are
smaller than those of both wild-type and p18/ mice and are
similar to those of Cdk4/ mice (Fig. 6).
Loss of p18 rescues S phase delay in MEFs lacking Cdk4.
Loss of CDK4 leads to a delay of the initiation of DNA rep-
lication of serum-deprived MEFs (49), indicating a role for
CDK4 in mediating the exit of MEFs from quiescence. The
studies on the signaling pathways regulating CDK4 and CDK6
have been mostly focused on the activation of cyclin D gene
expression (34). Whether any INK4 protein plays a role in this
FIG. 4. Loss of p18 did not rescue diabetes of Cdk4-deficient mice. (A) Glucose levels in serum of 3-, 7-, and 14-month-old mice. Three or four
mice from each genotype were examined. Standard deviation bars are indicated. (B) hematoxylin and eosin staining of pancreatic sections obtained
from mice of different genotypes from the same litter at 4 months age of. Arrows, islets. WT, wild type. (C) Percentages of islets containing 1 to
40, 41 to 400, or more than 400 cells/section in mice of different genotypes at 4 months of age. Two hundred fifty islets from WT and p18/
pancreases and 100 islets from Cdk4/ and p18/; Cdk4/ pancreases were counted. Bars, 200 m.
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regulation has not been reported. To determine the function of
p18 in the G0/G1-to-S transition, we derived MEFs from p18-
deficient mice and examined their response to serum starva-
tion by flow cytometry. Compared to what was found for wild-
type MEFs, deletion of p18 resulted in an accelerated
progression through the G1 phase and entry into S phase.
While 19.7 and 26.7% of p18/ MEFs have started DNA
replication at 18 and 21 h post-serum stimulation, respectively,
only 17.3 and 21.8% of wild-type MEFs were BrdU positive
(Fig. 7). Twenty-four hours post-serum stimulation, while
more (24.2%) wild-type MEFs continued to enter into S phase,
there was a decrease of BrdU-positive p18/ MEFs, indicat-
ing that most of them had completed DNA replication. The
cell cycle kinetics of p18/ MEFs in response to serum dep-
rivation-stimulation is in contrast to that of Cdk4/ MEFs,
which, as previously reported, displayed a delayed entry into S
phase relative to wild-type MEFs that was similar to that of
p27/ MEFs, which also had an accelerated progression
through the G1 phase.
The function of p18 in regulating the cellular response to
serum starvation-stimulation has not been previously reported.
To confirm this finding, we determined the expression of p18
gene transcripts during G1 progression. Early-passage
(younger than passage 4) MEFs were serum starved for 72 h
and then stimulated by the addition of 10% FBS. We previ-
ously reported that the p18 gene expresses two species of
message though promoter switching, a translation-competent
short transcript and a translation-attenuated long transcript,
due to the presence of a 1.2-kb 5-untranslated region encoded
by exon 1 (39). In serum-starved quiescent cells, the short
transcript accumulates to a low level while the long 2.4-kb
transcript was barely detectable (Fig. 7C). Following serum
stimulation, the levels of both transcripts increased and
reached a peak around the G1/S boundary. This result suggests
that the expression of p18 is regulated, at least in part, by a
transcriptional control and provides a molecular basis for the
accelerated G1-to-S progression of p18
/ MEFs.
To determine the functional interaction between CDK4 and
its two regulators, p18 and p27, we derived p18/; Cdk4/
and p27/; Cdk4/ double-mutant MEFs and determined
their cell cycle kinetics for serum deprivation and stimulation.
Consistent with a previous report (49), the p27/; Cdk4/
MEFs displayed cell cycle kinetics intermediate between those
of Cdk4/ and p27/ MEFs, indicating that deletion of p27
partially restored the delayed S-phase entry caused by Cdk4
loss (Fig. 7A and B). Surprisingly, p18/; Cdk4/ MEFs
exhibited kinetics more similar to that of p18/ MEFs: 20.1
and 25.4% of cells were stained positive for BrdU at 18 and
21 h post-serum stimulation. These results are consistent with
the idea that p18 plays a critical role in controlling the serum
response in MEFs by regulating not only CDK4 but also an-
other target, likely CDK6, and that delay in S phase entry due
to loss of Cdk4 could be compensated by an increase of CDK6
activity.
DISCUSSION
INK4 proteins specifically bind to and negatively regulate
the activity of CDK4 and CDK6 (44), and cyclin Ds-CDK4/6
complexes phosphorylate and functionally inactivate Rb family
proteins (9, 12, 22). Ectopic overexpression of individual INK4
genes causes a G1 cell cycle arrest with a correlative depen-
dency on the intact Rb (16), and loss of either Rb or a com-
bination of p107 and p130 effectively canceled the G1 arrest
caused by INK4 overexpression (3, 24, 35). Together, these
findings led to the widely accepted notion that, at least in
FIG. 5. p18 and Cdk4 are functional dispensable for normal development of the retina. Shown are histologic sections of retinas derived from
mice of different genotypes at 5 months of age. The ganglion cell layer (GCL), inner plexiform layer (IPL), inner nuclear layer (INL), outer
plexiform layer (OPL), outer nuclear layer (ONL), and rod-and-cone layer (RC) are indicated. Bars, 50 m.
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cultured cells and assays for controlling G1-to-S transition, the
primary functional targets of INK4 are CDK4 and CDK6 and
the primary functional targets of CDK4 and CDK6 are the
pocket proteins. Hence, there may exist in vivo a linear INK4-
CDK4/6-Rb G1 control pathway in mammalian cells. The no-
tion that CDK4 and CDK6 are the primary targets of INK4
function, however, has not been tested experimentally in any in
vivo setting, due largely to the lack of cells lacking both CDK4
and CDK6. Two additional proteins, orphan steroid receptor
Nur77 (5) and the p65RelA subunit of NF-	B (52), were re-
ported to bind with p19Ink4d and p16Ink4a, respectively, al-
though the functional consequence and physiologic signifi-
cance of both interactions remain unclear. Generation and
characterization of p18- and Cdk4-deficient mutant mouse
strains and development of a series of consistent phenotypes in
these two strains of mice provide an opportunity to determine
the functional dependency of INK4 on CDK4 in vivo. In this
paper, we provide the first genetic evidence that the develop-
mental function of an INK4 protein is dependent on CDK4.
We have examined in p18/, Cdk4/, and p18/;
Cdk4/ mice body weight and six cell types, tissues, or organs
which developed highly penetrant phenotypes because of the
loss of p18 alone: testis, ovary, pituitary, endocrine pancreas,
kidney, and adrenal gland. In all six cases, simultaneous loss of
Cdk4 virtually canceled all p18 loss-induced defects. These
results provide direct evidence that the function of p18Ink4c is
dependent on CDK4 in vivo. Many of these hyperproliferative
defects associated with p18 loss were also developed in p27-
deficient mice to a similar extent with a nearly complete pen-
etrance, including body weight increase; pituitary hyperplasia
and tumor development; and enlargement of thymus, spleen,
testis, and ovary (14, 23, 37). Notably, the body weight in-
FIG. 6. Histological analysis of kidneys and adrenal glands of p18 and Cdk4 mutant mice. (Top) Histologic sections of kidneys and adrenal
glands derived from mice of different genotypes at 4 months of age were examined microscopically. (Bottom) Gross appearance of kidneys and
adrenal glands. WT, wild type. Bars, 1 mm.
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FIG. 7. p18 has a function in serum response in MEFs that is not dependent on Cdk4. (A) Cell cycle analysis by staining with BrdU and
propidium iodide (PI). MEFs were starved for 72 h (time zero), followed by stimulation of cells with medium containing 10% serum. Cells were
pulse-labeled and harvested at the times indicated after stimulation. Cells were stained with an anti-BrdU antibody and PI and subjected to flow
cytometry. BrdU-positive cells are boxed. WT, wild type. (B) The percentage of cells in S phase from each time point was plotted on the basis of
flow-cytometric analysis. Results are average values of three independent experiments. Error bars indicate standard deviations of the means. ,
P  0.01, for comparison of p18/; Cdk4/ MEFs to Cdk4/ MEFs at the same times after serum restimulation; , P  0.05, for comparison
of p27/; Cdk4/ MEFs to Cdk4/ MEFs at the same times after serum restimulation; #, P  0.05, for comparison of p18/; Cdk4/ or
p27/; Cdk4/ MEFs to Cdk4/ MEFs at the same time point (Student’s t test). (C) Induction of p18 gene expression during G1 progression.
Total RNA was isolated from asynchronously growing (Asyn.) and serum-starved and stimulated MEFs. Twenty micrograms of each RNA sample
was resolved on a 1% agarose gel, transferred to a nitrocellulose filter, and hybridized with a probe derived from mouse p18 coding region.
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crease, or the gigantism phenotype, caused by p27 loss was only
partially canceled in p27/; Cdk4/ double-mutant mice
(Fig. 1). This result is consistent with and provides genetic
support for the model that, while INK4 regulates only CDK4
and CDK6, CIP/KIP proteins have an additional target, CDK2.
The role of p27 (and p21) in the regulation of Cdk4 is currently
controversial (38), and it has been suggested that p27 has
opposing roles as an activator (6) and as an inhibitor (1). Our
results that the body weights of p27/; Cdk4/ double-mu-
tant mice and the cell cycle kinetics of p27/; Cdk4/ MEFs
exhibited a phenotype intermediate between that of either
single mutant are in agreement with an oppose function of
these two genes and support the notion that p27 is an inhibitor
of Cdk4. In addition to tumor suppression, the Rb pathway
controls cell differentiation, tissue development, and organ
size. Of various p18 loss-caused defects that were canceled by
the simultaneous loss of Cdk4, the body weight increase, pan-
creatic islet number increase and size enlargement, and ovary
enlargement are defects in animal development and organ size
regulation, not tumor growth, indicating that the functional
dependency of p18 on Cdk4 is not restricted to tumor suppres-
sion and may extend into other cellular processes.
The only defect caused by p18 loss that was not significantly
alleviated by the loss of Cdk4 is the accelerated G1-to-S pro-
gression of MEFs following serum deprivation and stimula-
tion: p18/; Cdk4/ MEFs displayed cell cycle kinetics more
similar to that of p18/ MEFs (Fig. 7). In the same assay, the
p27/; Cdk4/ MEFs exhibited intermediate cell cycle ki-
netics, indicating, again, that deletion of Cdk4 partially re-
duced accelerated G1-to-S progression caused by p27 loss. The
most likely explanation for the lack of significant rescue of p18
loss-caused defects by Cdk4 loss is that in MEFs, unlike other
adult tissues and differentiated cells, Cdk6 may play a signifi-
cant role in regulating G1 progression following serum starva-
tion-stimulation, either in its own right or when induced in a
compensatory manner after Cdk4 loss, therefore sensitizing the
MEFs to p18 loss. Consistent with this idea, CDK6 is readily
detectable in MEFs and CDK6-p27 complexes were noticeably
increased in Cdk4 null MEFs (49), suggesting a compensatory
regulation of p27, and thus Cdk2, by CDK6 in the absence of
CDK4. The in vivo function of CDK6 in the whole animal and
how widely CDK6 compensates for CDK4 loss in other cell
types and tissues remain unclear. Our results that Cdk4 loss
canceled all six defects caused by p18 loss that we have exam-
ined suggest that Cdk6 plays a relatively minor role in vivo in
mediating the function of p18.
Wild-type MEFs accumulate in either G1 phase of the cell
cycle or a quiescence state in response to serum deprivation
and then reenter the cell cycle and travel through the G1 phase
with consistent kinetics: DNA replication starts approximately
14 to 16 h after serum stimulation. Loss of p18 accelerated G1
progression and initiation of DNA replication (Fig. 7), reveal-
ing a previously unrecognized function of p18 in regulation of
the serum response in MEFs. Supporting this function of p18
is the observation that p18 mRNA is induced during reentry of
serum-deprived MEFs into the cell cycle (Fig. 7). The mech-
anism responsible for p18 induction during G1 progression
remains to be determined but does not appear to be dependent
on the function of E2F1. Notably, similar percentages of
p18/ and wild-type MEFs (7 to 8%) were stained positive for
BrdU after 72 h of serum starvation (Fig. 7), indicating that
p18/ MEFs were arrested in the G0 quiescent state as effi-
ciently as wild-type MEFs. Likewise, loss of p27, which also
accelerated G1 progression following serum stimulation, did
not impair the ability of MEFs to enter and maintain a stable
quiescence upon serum deprivation. Differently, in response to
serum deprivation, the Rb/; p107/; p130/ triple-defi-
cient MEFs continue to incorporate BrdU and then undergo
apoptotic cell death (7, 43), indicating an essential function of
pocket proteins, and by extension implying a function of a
CDK inhibitor(s), in causing and/or maintaining G1 arrest un-
der growth-inhibiting conditions. Lack of a significant defect in
entering into and maintaining G1 arrest upon serum starvation
in p18-deficient MEFs is consistent with its decreased low-level
expression in quiescent cells (Fig. 7). It remains to be deter-
mined whether, during the cellular response to growth factor
deprivation-stimulation, p18 and p27 alone are sufficient to
cause and maintain a G1 arrest, but both are required for a
proper reentry of quiescent cells into the proliferation cycle.
Alternatively, our results suggest that another CDK inhibitor
protein separately controls the entry into and maintenance of
G1 arrest while p18 and p27 regulate the reentry into the cell
cycle.
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